GDF2 and Hepatic fibrosis: For example, we recently reported upregulation of BMP9 expression in HSC and determined its fibrogenic role in the chronic CCl4 mouse liver fibrosis model as well as in human patients with CLD, whereas BMP2 was proven to have antifibrotic effects in CCl4 and BDL models of liver fibrosis [90,91].